New prostate cancer injection aims to simplify hormone therapy

NCT ID NCT06395753

Recruiting now Disease control Sponsor: Debiopharm International SA Source: ClinicalTrials.gov ↗

Summary

This study is testing a new long-acting injection called Debio 4228 for men with advanced prostate cancer. The goal is to find the best dose that safely lowers testosterone levels to help control cancer growth. Researchers will measure how the drug moves through the body and how well it works in 66 participants over several months.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

AP Medical Research
RECRUITING

Miami, Florida, 33165, United States
AP-HP Hopital Pitie-Salpetriere
RECRUITING

Paris, 75013, France
AZ Delta
RECRUITING

Roeselare, 8800, Belgium
AZ Groeninge
RECRUITING

Kortrijk, 8500, Belgium
Advanced Urology
COMPLETED

Los Angeles, California, 90045, United States
Alarcon Urology Center
RECRUITING

Montebello, California, 90640, United States
Associated Urologists of North Carolina
RECRUITING

Raleigh, North Carolina, 27612, United States
Bakersfield Institute of Advanced Urology
RECRUITING

Bakersfield, California, 93301, United States
Biogenix Molecular
RECRUITING

Miami, Florida, 33165, United States
CHRU de Brest - Hopital Morvan
RECRUITING

Brest, 29200, France
CHU Angers
RECRUITING

Angers, 49933, France
CHU de Nantes - Hôtel Dieu
RECRUITING

Nantes, 44093, France
Carolina Urologic Research Center
RECRUITING

Myrtle Beach, South Carolina, 29572, United States
Centre Georges Francois Leclerc
RECRUITING

Dijon, 21000, France
Centre Jean Perrin
RECRUITING

Clermont-Ferrand, 63011, France
Corporacio Sanitaria Parc Tauli - Hospital de Sabadell
RECRUITING

Sabadell, 08208, Spain
East Valley Urology Center of Arizona
RECRUITING

Queen Creek, Arizona, 85140, United States
First Urology- Jeffersonville
RECRUITING

Jeffersonville, Indiana, 47130, United States
GU Research Network/Wichita Urology Group
RECRUITING

Wichita, Kansas, 67226, United States
Grimaldi Urology
RECRUITING

Chula Vista, California, 91910, United States
Hospital Clinic Barcelona
RECRUITING

Barcelona, 8036, Spain
Hospital Clinico San Carlos
RECRUITING

Madroñera, 28040, Spain
Hospital Universitario Vall d'Hebron
RECRUITING

Barcelona, 08035, Spain
Icahn School of Medicine at Mount Sinai
RECRUITING

New York, New York, 10029, United States
Instituto Valenciano de Oncologia
RECRUITING

Valencia, 46009, Spain
New York Cancer and Blood Specialists
RECRUITING

Shirley, New York, 11697, United States
Oregon Urology Institut
RECRUITING

Springfield, Oregon, 97477, United States
Pasadena Urological Medical Group
RECRUITING

Pasadena, California, 91101, United States
Summit Cancer Centers of North Spokane
RECRUITING

Spokane, Washington, 99208, United States
Tower Urology,
RECRUITING

Los Angeles, California, 90048, United States
University Hospital Gent
RECRUITING

Ghent, 9000, Belgium
Urologic Surgeons of Arizona
RECRUITING

Mesa, Arizona, 85206, United States
Urology Center of Southern California
RECRUITING

Murrieta, California, 92563, United States
Urology Clinics of North Texas
RECRUITING

Dallas, Texas, 75231, United States
Urology Group of Southern California
RECRUITING

Los Angeles, California, 90017, United States
Urology of Virginia
RECRUITING

Virginia Beach, Virginia, 23462, United States
Valley Urology
RECRUITING

Fresno, California, 93722, United States

Conditions

Explore the condition pages connected to this study.

PROSTATE CANCER